Home › Funds › Palo Alto Investors LP › NUVB

Palo Alto Investors LP position in NUVB

NUVATION BIO INC · Health Care

Palo Alto Investors LP reported holding 326,609 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 0.27% of its reported portfolio and ranking #43 among its reported holdings. Palo Alto Investors LP has disclosed NUVB holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)326.61K sh
Reported value held$1.83M
Portfolio Weight0.27%
First reportedQ1 2024
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Palo Alto Investors LP's NUVB position evolved

Palo Alto Investors LP first disclosed a stake in NUVB in Q1 2024 at 772,652 shares (US$2.8M). The position peaked in Q4 2025 at 538,079 shares, worth US$4.8M. Across 11 filings, Palo Alto Investors LP increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 326,609 shares valued at US$1.8M. Notable position changes include a 32% increase in Q3 2025 (shares rose 142% over the following quarter), a 47% trim in Q4 2025 (shares fell 52% over the following quarter), a 36% trim in Q2 2026 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 772.65K $2.81M New
Q2 2024 772.65K $2.26M Hold
Q3 2024 772.65K $1.77M Hold
Q4 2024 772.65K $2.06M Hold
Q1 2025 772.65K $1.36M Hold
Q2 2025 772.65K $1.51M Hold
Q3 2025 1.02M $3.78M Add
Q4 2025 538.08K $4.82M Reduce
Q1 2026 508.85K $2.18M Reduce
Q2 2026 326.61K $1.86M Reduce
Q3 2026 326.61K $1.83M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NUVB and 13F data

NUVB (NUVATION BIO INC) is a Health Care company. 56 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$145.3M), Context Capital Management, LLC (US$53.1M), Laurion Capital Management LP (US$43.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NUVB

All NUVB fund holders →

FAQ

How long has Palo Alto Investors LP held NUVB?

Palo Alto Investors LP has disclosed NUVB holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Palo Alto Investors LP's current position in NUVB?

As of Q3 2026, Palo Alto Investors LP holds 326.61K shares of NUVB (NUVATION BIO INC), valued at $1.83M, representing 0.27% of its reported portfolio and ranking #43.

Has Palo Alto Investors LP been buying or selling NUVB?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP held unchanged its position in NUVB. The position peaked in Q4 2025 at 538.08K shares.

Which other funds hold NUVB?

Other major institutional holders of NUVB include Decheng Capital LLC, Context Capital Management, LLC, Laurion Capital Management LP, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.